Sana D Karam Selected Research

Sana D Karam Research Topics

Disease

62	Neoplasms (Cancer) 11/2022 - 01/2012
23	Squamous Cell Carcinoma of Head and Neck 05/2022 - 01/2014
15	Head and Neck Neoplasms (Head and Neck Cancer) 11/2021 - 01/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 01/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 01/2017
4	Medulloblastoma 01/2017 - 04/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
3	Oropharyngeal Neoplasms 01/2019 - 11/2018
3	Carcinoma (Carcinomatosis) 11/2018 - 06/2012
3	Laryngeal Neoplasms (Laryngeal Cancer) 02/2017 - 01/2017
2	Adenocarcinoma 01/2022 - 04/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2019
2	Melanoma (Melanoma, Malignant) 10/2018 - 12/2017
2	Brain Neoplasms (Brain Tumor) 10/2018 - 12/2017
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Stomatitis 01/2022
1	Epstein-Barr Virus Infections 12/2021
1	Neoplasm Micrometastasis 11/2021
1	Ependymoma 12/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2019
1	Dehydration (Water Stress) 11/2018
1	Vomiting 11/2018
1	Nausea 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Diarrhea 11/2018
1	Dermatitis 10/2018
1	Anaplastic Thyroid Carcinoma 01/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2015
5	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
5	Cetuximab (Erbitux)FDA Link 01/2021 - 09/2017
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2018 - 04/2015
3	EphB4 ReceptorIBA 01/2022 - 12/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 09/2017
3	LigandsIBA 01/2017 - 04/2015
3	Phosphotransferases (Kinase)IBA 12/2016 - 04/2015
3	tyrosine receptor (receptor, tyrosine)IBA 12/2016 - 04/2015
2	InterferonsIBA 05/2022 - 01/2021
2	Antisense OligonucleotidesIBA 03/2022 - 04/2021
2	Biological ProductsIBA 01/2022 - 01/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 12/2019
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 11/2021
2	ChemokinesIBA 04/2021 - 01/2020
2	olaparibIBA 01/2020 - 10/2018
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 09/2015
2	Ephrin-B2 (Ephrin B2)IBA 01/2018 - 01/2017
2	EphrinsIBA 09/2015 - 04/2015
1	IntegrinsIBA 05/2022
1	Laminin (Merosin)IBA 05/2022
1	CarcinogensIBA 01/2022
1	tat Gene Products (tat Protein)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Ephrin-B1 (Ephrin B1)IBA 11/2021
1	flt3 ligand protein (flt3 ligand)IBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021
1	Angiotensin Receptor AntagonistsIBA 11/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	liquid crystal polymerIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Anaphylatoxin C5a ReceptorIBA 01/2021
1	Complement C3a (Complement 3a)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	DisintegrinsIBA 01/2021
1	AZD 8931IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2020
1	VimentinIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 12/2019
1	LipidsIBA 01/2019
1	atezolizumabIBA 01/2019
1	Collagenases (Collagenase)FDA Link 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	AntiemeticsIBA 11/2018
1	Carboplatin (JM8)FDA LinkGeneric 11/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018

Therapy/Procedure

39	Radiotherapy 06/2022 - 01/2012
25	Therapeutics 11/2022 - 01/2014
11	Immunotherapy 05/2022 - 01/2017
8	Drug Therapy (Chemotherapy) 01/2019 - 01/2014
4	Chemoradiotherapy 01/2022 - 01/2016
4	Aftercare (After-Treatment) 01/2019 - 01/2014
3	Neoadjuvant Therapy 01/2022 - 08/2017
3	Re-Irradiation 01/2021 - 06/2012
2	Radioimmunotherapy 11/2021 - 01/2019
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2018 - 01/2014
2	Induction Chemotherapy 02/2017 - 01/2017
2	Combined Modality Therapy 01/2016 - 01/2014
1	Pancreatectomy 01/2022
1	Esophagectomy 08/2019
1	Pain Management 01/2019